TNF and Hypoglycemia: Inconsistent with the reported results [8], we found that injection of a relatively high dose of anti-TNF-α neutralizing antibodies (50 μg/mouse) failed to reverse hypoglycemia caused by anti-CD3 administration (Figure 6(d)).